Malignant Brain Stem Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-12-16
Clinical Trial Update: Anlotinib to Malignant Brainstem Glioma [Phase 2]
Phase 2 trial update evaluating anlotinib in malignant brain stem glioma and glioma.